SCS Capital Management LLC Purchases Shares of 4,609 UnitedHealth Group Incorporated $UNH

Key Points

• SCS Capital Management LLC has acquired a new stake in UnitedHealth Group, purchasing 4,609 shares valued at approximately $2.41 million in the first quarter of the year.
• Despite reporting quarterly earnings that missed analysts' expectations with an EPS of $4.08 compared to a consensus estimate of $4.45, the company saw a year-over-year revenue increase of 12.9%.
• UnitedHealth Group recently declared a quarterly dividend of $2.21 per share, reflecting an annualized basis of $8.84 and a yield of 2.5%, with a payout ratio of 38.30%.

SCS Capital Management LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,609 shares of the healthcare conglomerate's stock, valued at approximately $2,414,000.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Bayforest Capital Ltd lifted its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 50 shares during the period. Copia Wealth Management bought a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $42,000. IAG Wealth Partners LLC bought a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $42,000. Finally, Investment Management Corp VA ADV bought a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $44,000. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Wolfe Research decreased their target price on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Baird R W lowered shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. TD Securities reiterated a "hold" rating and set a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Morgan Stanley decreased their price objective on UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating for the company in a report on Wednesday, August 20th. Finally, Oppenheimer decreased their price objective on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $355.77.

UnitedHealth Group Stock Up 2.1%

Shares of UNH stock traded up $7.11 during trading hours on Thursday, reaching $353.89. 18,916,413 shares of the company's stock were exchanged, compared to its average volume of 19,187,298. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a market cap of $320.51 billion, a PE ratio of 15.33, a PEG ratio of 2.27 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock's fifty day moving average price is $291.11 and its two-hundred day moving average price is $370.48.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 EPS. UnitedHealth Group's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.